Skip to main content

Table 2 Univariate analysis with respect to 5-year survival of the patients with non-small cell lung cancer

From: Kinesin superfamily protein 21B acts as an oncogene in non-small cell lung cancer

Clinical featuresPatients5-year survival (%)P Valueb
PatientsRate (%)
722940.3
 Gender   0.352
  Male401537.5 
  Female321443.8 
 Age, year   0.624
  < 60311238.7 
  ≥ 60411741.5 
 Smoking   0.182
  No482245.8 
  Yes24729.2 
 Histological type   0.115
  SCC32928.1 
  ADC402050.0 
 Differentiation   0.035
  Well13646.2 
  Moderately442045.5 
  Poorly15320.0 
 pT   0.069
  pT111872.7 
  pT2512039.2 
  pT310110.0 
 pN   0.001
  −241979.2 
  +481020.8 
 pTNM   0.001
  pI1515100.0 
  pII421331.0 
  pIIIa1516.7 
 Chemotherapy   0.893
  No10440.0 
  Yes622540.3 
 Radiotherapy   0.801
  No451840.0 
  Yes271140.7 
 EGFR-TKI therapy   0.788
  No401742.5 
  Yes321237.5 
 KIF21B   0.001
  Low281864.3 
  High441125.0 
  1. SCC squamous cell carcinoma, ADC adenocarcinoma, pT tumor size, pN lymph node metastasis, pTNM tumor stage, EGFR-TKI growth factor receptor-tyrosine kinase inhibitor
  2. P Valueb: Log-rank test